ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 93 filers reported holding ENZO BIOCHEM INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $213,000 | +5.4% | 41,800 | +23.6% | 0.01% | -25.0% |
| Q2 2016 | $202,000 | +146.3% | 33,820 | +86.9% | 0.02% | +220.0% |
| Q1 2016 | $82,000 | +1.2% | 18,100 | 0.0% | 0.01% | -54.5% |
| Q4 2015 | $81,000 | -37.7% | 18,100 | -38.2% | 0.01% | -15.4% |
| Q4 2014 | $130,000 | +7.4% | 29,300 | +24.7% | 0.01% | +333.3% |
| Q3 2014 | $121,000 | -1.6% | 23,500 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $123,000 | – | 23,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
| VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
| AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
| Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
| Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
| Corsair Capital Management | 58,657 | $188,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |